All articles by Linda Stewart – Page 7
-
NewsPromising new class of antimalarial drugs discovered
A new study identifies an inhibitor of gene regulation that specifically kills the malaria pathogen. The chromatin remodeler PfSnf2L is a key regulator of genes that play an important role in various stages of the pathogen’s development.
-
NewsStudy calls for better measures of poverty to strengthen tuberculosis research
A new review examines existing methods for assessing socioeconomic status in TB studies and highlights their shortcomings. The authors call for better, standardized poverty metrics to improve research and policy.
-
NewsScottish bio-tech company secures £3.4m investment
Scottish biotech engineering company uFraction8 has secured £3.4m in new investment following the completion of a funding round led by Foresight Group.
-
NewsChlorine plus UV light degrades toxins caused by harmful algae blooms
Scientists examining the combination of ultraviolet light and chlorine to detoxify water laden with toxins from cyanobacteria have demonstrated that this combination significantly enhanced the degradation of toxins compared to chlorine alone.
-
NewsPaxlovid’s impact on hospitalization and death in COVID-vaccinated older adults far weaker than previously thought
A new study overturns the assumption that Paxlovid’s effectiveness in reducing COVID-19 hospitalizations and deaths in unvaccinated adults also applies to vaccinated adults.
-
NewsGroundbreaking study shows potential of new mRNA vaccine to help fight tuberculosis
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials. The mRNA vaccine was successful in triggering an immune defence response that helped to reduce TB numbers in infected mice.
-
NewsScientists warn of increased mpox transmission
International researchers warn that the ongoing mpox outbreak in the Democratic Republic of the Congo (DRC) has the potential to spread across borders more rapidly. The mpox virus has mutated, and the new variant, clade 1b, has become more infectious.
-
NewsScientists uncover how bacterial resistance to synergistic drug treatments is arising
Scientists investigating the potential of combined and more powerful drug treatments have found that antimicrobial resistance to these is arising via the vitamin B2 synthesis pathway.
-
NewsMachine learning framework can decipher immune system’s record of past infections
A novel machine learning framework can decipher an individual’s immune system’s record of past infections and diseases, providing a powerful tool with the potential for diagnosing autoimmune disorders, viral infections, and vaccine responses with precision.
-
NewsDigging into a decades-old hepatitis B mystery suggests a new potential treatment
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, researchers have identified a vulnerability that opens the door to new treatments.
-
NewsResilient algae may speed up Greenland ice melt
Microscopic algae darken glacier surfaces and can accelerate melting. A new study investigating where the small algae get the necessary nutrients to survive in this hostile environment reveals how they absorb and store nutrients.
-
NewsCoffee grounds and Reishi mushroom spores can be 3D printed into a compostable alternative to plastics
Researchers have developed a new system for turning coffee grounds into a paste, which is inoculated with Reishi mushroom spores to form a mycelial skin. The skin turns the coffee grounds into a resilient, fully compostable 3D printable alternative to plastics.
-
NewsExpedition confirms spread of highly pathogenic avian influenza virus in the Weddell Sea
The CSIC-UNESPA scientific expedition monitoring the presence of the highly pathogenic avian influenza virus (HPAI H5N1) in Antarctica has confirmed the presence of the virus in all species detected on six islands in the Weddell Sea.
-
NewsNovel antibiotic BTZ-043 also reaches tuberculosis bacteria hiding in dead lung tissue
Researchers have shown that the novel antibiotic BTZ-043 effectively penetrates tubercolous lesions and accumulates there in high concentrations. Consequently, the drug can fight Mtb bacteria even in hard-to-reach areas.
-
News1 in 5 older adults get infections after heart surgery, and women have a 60% higher risk
One in five older adults gets an infection up to six months after heart surgery, with women far more likely to develop one, according to two studies which examined thousands of cases of coronary artery bypass grafting.
-
NewsResearchers ID key immune differences that make one West African ethnic group less susceptible to malaria
Researchers have uncovered how genetic and lifestyle factors influence immune responses to malaria in children from two large West African ethnic groups. Children showed key differences in immune cell activity offering greater protection.
-
NewsTransforming HIV diagnosis: a low-cost, point-of-care detection solution
A team of researchers has developed an innovative handheld device for human immunodeficiency virus (HIV) detection that combines paper-based sample preparation with real-time isothermal amplification.
-
NewsAMI member Christopher Stewart named as finalist in 2025 UK Blavatnik Awards for Young Scientists
Applied Microbiology International member Dr Christopher Stewart of Newcastle University has been named as a finalist for the eighth Blavatnik Awards for Young Scientists in the UK. He is the 2023 winner of AMI’s WH Pierce Prize for microbiology.
-
NewsMass polio vaccination campaign to continue in the Gaza Strip
The emergency polio outbreak response in the Gaza Strip is continuing, with a mass vaccination campaign scheduled from 22 to 26 February 2025. The novel oral polio vaccine type 2 (nOPV2) will be administered to over 591,000 children under 10 years of age.
-
NewsGround-breaking technique deploys bacterium to deliver drugs directly to the brain
A landmark study using the nasal bacteria technique promises new treatments for neurological disorders by bypassing the blood-brain barrier.